Date published: 2026-5-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

ADAMTS-8 Inhibitors

ADAMTS-8 inhibitors represent a specialized class of chemical compounds engineered to exert precise control over the activity of ADAMTS-8, an enzyme belonging to the ADAMTS (A Disintegrin-like And Metalloproteinase with Thrombospondin type-1 motif) family. These enzymes are integral components of the body's extracellular matrix (ECM) remodeling machinery. ADAMTS-8, in particular, plays a pivotal role in regulating essential physiological processes like cartilage development, angiogenesis, and tissue repair. By specifically targeting ADAMTS-8, inhibitors can modulate its enzymatic functions, influencing the degradation and reconstruction of ECM components.ADAMTS-8 inhibitors are at the forefront of scientific exploration due to their potential to uncover critical insights into ECM dynamics. These compounds offer a valuable tool for investigating the fundamental mechanisms of tissue maintenance and regeneration.

Their selective interference with ADAMTS-8's enzymatic activities enables researchers to dissect the enzyme's role in both normal and pathological conditions. This knowledge can inform advancements in tissue engineering and regenerative medicine, aiding the development of innovative biomaterials and strategies to enhance tissue repair. Furthermore, ADAMTS-8 inhibitors can be instrumental in elucidating the intricate interplay of ECM components and their influence on cell behavior, paving the way for a deeper understanding of tissue physiology. In conclusion, ADAMTS-8 inhibitors represent a chemically distinct class of compounds with a specific purpose: to modulate the activity of the ADAMTS-8 enzyme. While their primary application is in research, these inhibitors have the potential to unlock critical insights into ECM dynamics and tissue physiology. Their selective targeting of ADAMTS-8 may contribute to advancements in fields such as tissue engineering and biomaterial development, ultimately shaping our understanding of tissue maintenance and repair.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

TAPI-1

171235-71-5sc-222337
1 mg
$669.00
15
(1)

Broad-spectrum metalloproteinase inhibitor that may inhibit ADAMTS-8 by chelating the catalytic zinc ion.

Batimastat

130370-60-4sc-203833
sc-203833A
1 mg
10 mg
$179.00
$377.00
24
(1)

A synthetic matrix metalloproteinase (MMP) inhibitor that may have inhibitory effects on ADAMTS-8.

Marimastat

154039-60-8sc-202223
sc-202223A
sc-202223B
sc-202223C
sc-202223E
5 mg
10 mg
25 mg
50 mg
400 mg
$168.00
$218.00
$404.00
$629.00
$4900.00
19
(1)

Another MMP inhibitor that may indirectly affect ADAMTS-8 activity by targeting related metalloproteinases.

GM 6001

142880-36-2sc-203979
sc-203979A
1 mg
5 mg
$77.00
$270.00
55
(1)

A broad-spectrum metalloproteinase inhibitor that can potentially inhibit ADAMTS-8 enzymatic activity.

Prinomastat

192329-42-3sc-507449
5 mg
$190.00
(0)

An MMP inhibitor that might indirectly influence ADAMTS-8 activity by suppressing related metalloproteinases.

ARP 100

704888-90-4sc-203522
5 mg
$208.00
26
(1)

A broad-spectrum metalloproteinase inhibitor that may affect ADAMTS-8 enzymatic function through zinc ion chelation.

SB-3CT

292605-14-2sc-205847
sc-205847A
1 mg
5 mg
$102.00
$388.00
15
(1)

A selective inhibitor of MMP-2 and MMP-9, which may impact ADAMTS-8 indirectly by modulating the extracellular matrix.